Bristol-Myers Squibb – Stock Analysis
The irrational exuberance we are currently witnessing has led to a significant reduction in the number of attractively valued high-quality companies. Despite this challenge, however, there are some companies with the potential to generate an attractive total return. This Bristol-Myers Squibb stock analysis explains why BMY is one such company. Despite its attractiveness, I do [...]